Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3226 of 6351
-
Brain training shows promise for long COVID brain fog in seniors
Symptom relief CompletedThis research is being done to collect preliminary data on the potential of computerized "brain-training" exercises for treating Long COVID symptoms in older adults. The investigators hypothesize that computerized brain-training will be an acceptable and feasible intervention for…
Sponsor: UConn Health • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
AI and VR join forces to fight severe facial pain
Knowledge-focused By invitation onlyTrigeminal neuralgia (TN) is the most common cause of facial pain. Medical treatment is the first therapeutic choice whereas surgery, including Gamma Knife radiosurgery (GKRS), is indicated in case of pharmacological therapy failure. However, about 20% of subjects lack adequate p…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
App and brain zaps offer new hope for teen cancer survivors in pain
Symptom relief CompletedThis is a prospective study that will conduct a series of focus groups with non-Hispanic Black and Hispanic childhood cancer survivors to obtain their input on culturally adapting a mobile CBT program for chronic pain and tDCS procedures. Once this adaptation process is completed…
Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
New program aims to lower blood pressure in black pregnant women through community support and technology
Disease control CompletedThis study will determine the feasibility and acceptability of the Protective Assets Reinforced with Integrated care and TechnologY (PARITY) program, to test the clinical, behavioral, and strength building efficacy of the PARITY program and explore how it achieves its outcomes in…
Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Talking through birth fears: study tests psychoeducation for Moms-to-Be
Symptom relief CompletedThe aim of this study is to evaluate the effects of a prenatal psychoeducation program applied to pregnant women with a traumatic perception of birth on the perception of traumatic birth, maternal attachment, breastfeeding and postpartum depression.
Sponsor: Burcu Firat • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Harlem launches bold mental health coalition to tackle depression and anxiety
Knowledge-focused Recruiting nowAddressing health disparities, especially in the face of coronavirus pandemic, requires an integrated multi-sector equity-focused, community-based approach. This study will examine the impact of Harlem Strong Community Mental Health Collaborative, a community-wide multi-sectoral …
Sponsor: City University of New York, School of Public Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Study probes hidden factors that worsen asthma during exercise
Knowledge-focused OngoingThis is a single-center study of 80 subjects with asthma including those with obesity and metabolic dysfunction (MD), those with obesity and without metabolic dysfunction, those with severe asthma and mucus plugging and those with severe asthma and without mucus plugging. Screeni…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
New mRNA flu shot enters human testing
Vaccine CompletedThis is a Phase 1, single-site, open-label, comparator-controlled dose escalating study of an intramuscularly (IM) administered mRNA-LNP vaccine encoding for (Vaccine Research Center) VRC H1ssF 3928 of up to 50 healthy adult volunteers aged 18 to 49 years, inclusive. This study i…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 14:00 UTC
-
Music as medicine: study tests whether tunes can tame depression
Symptom relief CompletedThe study team sought to scientifically investigate strategic subsets of depressed individuals or people prone to or at-risk of depression through music experiences of individual, group, and blended supported contexts. Meetings with the study multi-disciplinary team, included mem…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Computer-Guided implant surgery aims to rebuild smiles for patients with severe jaw bone loss
Disease control CompletedEvaluation of computer guided placement of Zygomatic implants utilizing intra sinus versus extra sinus surgical approach for the reconstruction of atrophic maxilla. The expected benefit from the current study is to select the most suitable approach for Zygomatic implant placement…
Sponsor: Cairo University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can a smartphone app boost quality of life for young cancer patients?
Symptom relief OngoingApproximately 2,200 cancers per year in France are diagnosed within the adolescents and young adults population (15-25 years old, AYA). The cancer plans and the INCA recommend support during and after cancer treatment, taking into account both medical and psycho-social specificit…
Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Can aspirin or diabetes drugs tame fatty liver? new study reveals results
Disease control CompletedNon-alcoholic fatty liver disease (NAFLD), currently referred to as metabolic dysfunction-associated steatotic liver disease (MASLD), is a common hepatic manifestation of metabolic dysfunction and may progress from simple steatosis to steatohepatitis, fibrosis, cirrhosis, and hep…
Sponsor: Galala University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New hope for tough cancers: revumenib trial shows promise
Disease control Stopped earlyThis study will evaluate the safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of revumenib in participants with colorectal cancer (CRC) or other solid tumors who have failed at least 1 prior line of therapy.
Phase 1/2 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New gel could replace hormone cream for menopause discomfort
Symptom relief Recruiting nowThe goal of this randomized controlled trial is to test the efficacy of StrataMGT in the management of Genitourinary Syndrome of Menopause (GSM) compared to estrogen therapy. The main question it aims to answer is: \- Will StrataMGT be non-inferior regarding patient quality of l…
Sponsor: Stratpharma AG • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New pill targets hard-to-treat blood cancers in early trial
Disease control Recruiting nowThis phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia and Myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap neoplasms that has come back (recurrent) or that does…
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New pill targets Hard-to-Treat blood cancers in early human trial
Disease control OngoingB-cell malignancies are a group of cancers of B lymphocytes, a type of white blood cell responsible for fighting infections. The purpose of this study is to assess safety, tolerability, pharmacokinetics and preliminary efficacy of ABBV-525 as a monotherapy. ABBV-525 is an invest…
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Ketamine's Suicide-Fighting secret under the microscope
Knowledge-focused Recruiting nowThe purpose of this study is to test the hypothesis that the anti-depressant and anti-suicidal effects of the N-methyl-D-aspartate receptor (NMDAR) antagonist Ketamine is critically dependent on stimulation of Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid receptors (A…
Phase 2 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Diabetes drug takes on childhood cancers in early safety trial
Disease control Recruiting nowThis is a pilot phase Ib study of the safety of dapagliflozin (in addition to standard of care treatment) for the treatment of pediatric patients with recurrent brain tumors and relapsed/refractory solid tumors. The primary hypothesis is that dapagliflozin is well-tolerated and s…
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Mindfulness vs. sleep class: which helps college students catch more Zzz's?
Symptom relief Recruiting nowSleep disturbance has a range of negative effects on psychosocial and biological processes important for academic and social success as well as mental and physical health among adolescents and young adults. Limited, inconsistent, and poor quality sleep lead to anxiety, depressive…
Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Mind over MRI: stroke patients learn to rewire reading skills
Knowledge-focused Recruiting nowThe overall goal of this project is to advance a biologically-based approach to treatment of reading disorders after stroke, which will expand the limits of cognitive rehabilitation. Using a novel brain imaging technique, called real-time functional magnetic resonance imaging (fM…
Sponsor: Kessler Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC